Cargando…

CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo

Background: Noncontact Electro Capacitive Cancer Therapy (ECCT) is a novel treatment modality in cancer. Chemokine (C-C motif) ligand 2 (CCL2) has a major role in the outgrowth of metastatic breast cancer. Interleukin 18 (IL18) plays a role in macrophage alteration, which leads to excessive angiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratiwi, Rarastoeti, Antara, Nyoman Yudi, Fadliansyah, Lalu Gunawan, Ardiansyah, Syamsul Arif, Nurhidayat, Luthfi, Sholikhah, Eti Nurwening, Sunarti, Sunarti, Widyarini, Sitarina, Fadhlurrahman, Ahmad Ghitha, Fatmasari, Hindana, Tunjung, Woro Anindito Sri, Haryana, Sofia Mubarika, Alamsyah, Firman, Taruno, Warsito Purwo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348523/
https://www.ncbi.nlm.nih.gov/pubmed/32695310
http://dx.doi.org/10.12688/f1000research.20727.2
_version_ 1783556847040462848
author Pratiwi, Rarastoeti
Antara, Nyoman Yudi
Fadliansyah, Lalu Gunawan
Ardiansyah, Syamsul Arif
Nurhidayat, Luthfi
Sholikhah, Eti Nurwening
Sunarti, Sunarti
Widyarini, Sitarina
Fadhlurrahman, Ahmad Ghitha
Fatmasari, Hindana
Tunjung, Woro Anindito Sri
Haryana, Sofia Mubarika
Alamsyah, Firman
Taruno, Warsito Purwo
author_facet Pratiwi, Rarastoeti
Antara, Nyoman Yudi
Fadliansyah, Lalu Gunawan
Ardiansyah, Syamsul Arif
Nurhidayat, Luthfi
Sholikhah, Eti Nurwening
Sunarti, Sunarti
Widyarini, Sitarina
Fadhlurrahman, Ahmad Ghitha
Fatmasari, Hindana
Tunjung, Woro Anindito Sri
Haryana, Sofia Mubarika
Alamsyah, Firman
Taruno, Warsito Purwo
author_sort Pratiwi, Rarastoeti
collection PubMed
description Background: Noncontact Electro Capacitive Cancer Therapy (ECCT) is a novel treatment modality in cancer. Chemokine (C-C motif) ligand 2 (CCL2) has a major role in the outgrowth of metastatic breast cancer. Interleukin 18 (IL18) plays a role in macrophage alteration, which leads to excessive angiogenesis. This study aims to elaborate on the association of CCL2, IL18, IL23α, and TNF-α (tumor necrosis factor-alpha) expression with the anti-proliferative effect of ECCT in rat breast tumor tissue.   Methods: Low intensity (18 Vpp) and intermediate frequency (150 kHz) alternating current-electric field (AC-EF) between two capacitive electrodes were exposed as external EF to a rat cage. Twenty-four rats were divided into four groups of six replicates. Breast tumor tissues were collected from 7, 12-dimethylbenz[a]anthracene (DMBA)-induced rats. Two groups were non DMBA-induced rats without ECCT exposure (NINT) and with (NIT). The other two groups were DMBA-induced rats without ECCT exposure (INT) and with (IT). Mammary glands and breast tumor tissues were collected from each group and preserved. Hematoxylin-eosin and immunohistochemistry staining were performed on paraffin sections of tissues using anti-PCNA, anti-ErbB2, anti-Caspase3, and anti-CD68. CCL2, IL18, IL23α, and TNF-α mRNA relative expressions were analyzed using qRT-PCR. Results: ECCT exposure may cause the reduction of PCNA protein expression as well as ErbB2 on breast tumor tissues, but it causes the increase of Caspase3 and macrophage CD68 protein. In rat breast tumor tissues of IT groups, the mRNA expression of CCL2 and IL18 are significantly down-regulated, in contrast with the up-regulated expression of these cytokines in tumor tissues of the INT group. IL23α and TNF- α expression remained similar in both groups. Conclusion: CCL2 and IL18 expressions have an association with the inhibition of breast tumor cell proliferation affected by ECCT exposure
format Online
Article
Text
id pubmed-7348523
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-73485232020-07-20 CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo Pratiwi, Rarastoeti Antara, Nyoman Yudi Fadliansyah, Lalu Gunawan Ardiansyah, Syamsul Arif Nurhidayat, Luthfi Sholikhah, Eti Nurwening Sunarti, Sunarti Widyarini, Sitarina Fadhlurrahman, Ahmad Ghitha Fatmasari, Hindana Tunjung, Woro Anindito Sri Haryana, Sofia Mubarika Alamsyah, Firman Taruno, Warsito Purwo F1000Res Research Article Background: Noncontact Electro Capacitive Cancer Therapy (ECCT) is a novel treatment modality in cancer. Chemokine (C-C motif) ligand 2 (CCL2) has a major role in the outgrowth of metastatic breast cancer. Interleukin 18 (IL18) plays a role in macrophage alteration, which leads to excessive angiogenesis. This study aims to elaborate on the association of CCL2, IL18, IL23α, and TNF-α (tumor necrosis factor-alpha) expression with the anti-proliferative effect of ECCT in rat breast tumor tissue.   Methods: Low intensity (18 Vpp) and intermediate frequency (150 kHz) alternating current-electric field (AC-EF) between two capacitive electrodes were exposed as external EF to a rat cage. Twenty-four rats were divided into four groups of six replicates. Breast tumor tissues were collected from 7, 12-dimethylbenz[a]anthracene (DMBA)-induced rats. Two groups were non DMBA-induced rats without ECCT exposure (NINT) and with (NIT). The other two groups were DMBA-induced rats without ECCT exposure (INT) and with (IT). Mammary glands and breast tumor tissues were collected from each group and preserved. Hematoxylin-eosin and immunohistochemistry staining were performed on paraffin sections of tissues using anti-PCNA, anti-ErbB2, anti-Caspase3, and anti-CD68. CCL2, IL18, IL23α, and TNF-α mRNA relative expressions were analyzed using qRT-PCR. Results: ECCT exposure may cause the reduction of PCNA protein expression as well as ErbB2 on breast tumor tissues, but it causes the increase of Caspase3 and macrophage CD68 protein. In rat breast tumor tissues of IT groups, the mRNA expression of CCL2 and IL18 are significantly down-regulated, in contrast with the up-regulated expression of these cytokines in tumor tissues of the INT group. IL23α and TNF- α expression remained similar in both groups. Conclusion: CCL2 and IL18 expressions have an association with the inhibition of breast tumor cell proliferation affected by ECCT exposure F1000 Research Limited 2020-07-23 /pmc/articles/PMC7348523/ /pubmed/32695310 http://dx.doi.org/10.12688/f1000research.20727.2 Text en Copyright: © 2020 Pratiwi R et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pratiwi, Rarastoeti
Antara, Nyoman Yudi
Fadliansyah, Lalu Gunawan
Ardiansyah, Syamsul Arif
Nurhidayat, Luthfi
Sholikhah, Eti Nurwening
Sunarti, Sunarti
Widyarini, Sitarina
Fadhlurrahman, Ahmad Ghitha
Fatmasari, Hindana
Tunjung, Woro Anindito Sri
Haryana, Sofia Mubarika
Alamsyah, Firman
Taruno, Warsito Purwo
CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title_full CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title_fullStr CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title_full_unstemmed CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title_short CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
title_sort ccl2 and il18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348523/
https://www.ncbi.nlm.nih.gov/pubmed/32695310
http://dx.doi.org/10.12688/f1000research.20727.2
work_keys_str_mv AT pratiwirarastoeti ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT antaranyomanyudi ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT fadliansyahlalugunawan ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT ardiansyahsyamsularif ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT nurhidayatluthfi ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT sholikhahetinurwening ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT sunartisunarti ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT widyarinisitarina ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT fadhlurrahmanahmadghitha ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT fatmasarihindana ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT tunjungworoaninditosri ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT haryanasofiamubarika ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT alamsyahfirman ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo
AT tarunowarsitopurwo ccl2andil18expressionsmayassociatewiththeantiproliferativeeffectofnoncontactelectrocapacitivecancertherapyinvivo